GLYCANOSTICS WINS NATIONAL ROUND OF CENTRAL EUROPEAN STARTUP AWARDS
With the unique, glycan-based technology and possible benefits forpatients, clinicians and society, Glycanostics was announced as a CESA awardwinner in two independent categories – Best Health-Tech Startup and Best SocialImpact Startup. As a winner in the latter category, Glycanostics became a partof this year´s Accace life accelerator (by Accace company), which ended up withan investor […]
GLYCANOSTICS WINS HORIZON 2020 GRANT
After receiving the prestigious “Seal of Excellence” from the European Commission on October 23, 2018, Glycanostics’ next submission, to the Horizon 2020 Programme, won a € 50 000 grant. The Horizon 2020 Programme for Research and Innovation 2014-2020 aims to support excellent science, industrial leadership and social impact startups. Its main goal is to ensure that European countries […]
GLYCANOSTICS RECEIVES THE PRESTIGIOUS HORIZON 2020 “SEAL OF EXCELLENCE”
The European Commission awarded Glycanostics the prestigious Seal of Excellence for its revolutionary prostate cancer early diagnostic tests. This project was submitted under the Horizon 2020 Programme for Research and Innovation 2014-2020, and received the highest scores for its proposal in the extremely competitive evaluation process. The European Commission has a rigorous evaluation system—with a panel of […]
GLYCANOSTICS WINS TOP-6 BEST STARTUPS IN CENTRAL EUROPE
The FutureNow startup competition, also known as the Startup Awards, is akin to the Oscars for the best startups with global potential. This year marked the eighth and largest occurrence of the competition, open to participants from 17 European countries, with 128 registered start-ups. Glycanostics was chosen as a finalist in the Grand Finale with […]
GLYCANOSTICS SUCCESFULLY FINISHED HORIZON 2020 SME INSTRUMENT 1 GRANT
In august 2019, Glycanostics successfully finished the first phase of SME Instrument, by finishing a feasibility study and a business plan with the help from advisors and a consultation agency. Further information are in the Publishable summary, which can be downloaded from this link.
GLYCANOSTICS WINS THE EUROPEAN RESEARCH COUNCIL GRANT
Glycanostics innovations are again supported and highly ranked by leading industry experts. This time the company won the European Research Council (ERC) Proof of Concept Grant. The ERC president Jean Pierre Bourguignon mentioned that their Pannel recommended Glycanostics proposal for funding at the sufficiently high position in the rank list. He is confident that the grant […]
GLYCANOSTICS TAKES 3RD PLACE IN VODAFONE’S IDEA OF THE YEAR COMPETITION
We are excited to announce that Glycanostics placed third in Vodafone’s Idea of the Year 2018 competition, a prestigious event for early-stage startups. The competition’s objectives are to actively support innovative projects with high market potential by providing mentoring, mediating investments worth up to CZK 10 million, internationalizing projects, and establishing beneficial contacts. It’s the […]
JAN TKAC AND TOMAS BERTOK – SCIENTISTS OF THE YEAR AWARD WINNERS – ESTABLISH GLYCANOSTICS TO BRING THEIR REVOLUTIONARY INNOVATION TO CANCER DIAGNOSTICS MARKET
Glycanostics is an innovative start-up company established in 2017 to bring its revolutionary cancer diagnostics products to the US and EU markets. The company was founded by two remarkable scientists PhD Jan Tkac and PhD Tomas Bertok who got international recognition for their scientific works, prestigious grants and awards winners such as Scientists of the year (Slovakia), […]
